Related Experiment Videos
Long-term immune dysfunction after radiotherapy to the head and neck area
Emma L Verastegui1, Rocio B Morales, Jose L Barrera-Franco
1Department of Immunology, Instituto Nacional de Cancerologia, Avenida San Fernando 22, Tlalpan 14000 D.F., México City, Mexico. incaninm@mexis.com
International Immunopharmacology
|July 16, 2003
Summary
Radiotherapy, especially for head and neck cancers, can cause prolonged immune system damage, leading to severe lymphopenia and impacting long-term survival. Recovery of immune cells is slow, correlating with disease recurrence.
Area of Science:
- Immunology
- Oncology
- Radiotherapy Research
Background:
- Radiotherapy in limited fields typically doesn't cause hematological side effects.
- Head and neck cancer patients undergoing radiation often experience chronic infections, with xerostomia implicated, but immune alterations are overlooked.
Purpose of the Study:
- To assess the impact of radiotherapy on immune function across different anatomical sites.
- To analyze lymphocyte counts, T-cell subsets, and their relation to infections and survival.
Main Methods:
- Evaluated 70 patients (50 head and neck, 10 cervical, 10 CNS tumors) during and after radiotherapy.
- Analyzed lymphocyte counts and T-cell subsets (CD4+, CD8+).
- Correlated immune changes with intracellular infections and disease-free survival.
Main Results:
- Severe lymphopenia observed in head and neck and cervical cancer patients by week 5.
- Head and neck and cervical cancer patients showed reduced B cells and T lymphocytes (CD4+, CD8+).
- Cervical cancer patients recovered lymphocyte counts by 24 months, but T-cell subsets lagged; head and neck patients showed no full recovery by 60 months. Recurrence correlated with low lymphocyte counts.
Conclusions:
- The head and neck region is particularly vulnerable to radiotherapy-induced immune alterations due to its lymphoid cell reservoir.
- Impaired immune recovery may limit antigen recognition, affecting survival.
- Prolonged immune dysfunction following radiotherapy can significantly impact long-term patient outcomes.